Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Point-of-Care Quantification of H3.1-Nucleosomes in Fresh Whole Blood: A Novel Tool For NETs Measurement In Hospital Setting

Monday, October 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presents a novel point-of-care tool for quantifying H3.1-nucleosomes in fresh whole blood, aimed at measuring NETs in hospital settings. This innovative approach could enhance patient care by providing timely diagnostics. The project is supported by the Walloon Region, highlighting its significance in clinical applications.
Price reaction · baseline $12.96 (2025-10-03 close) · hit pre-market · 2 other VNRX headline(s) in the window, move may be shared
day 0 close
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of a novel tool for measuring NETs.
  • Potential for improved patient care in hospital settings.
  • Research supported by the Walloon Region.

Full Press Release Details

Poster titled: Point-of-Care Quantification of H3.1-Nucleosomes in Fresh Whole Blood: A Novel Tool For NETs Measurement In Hospital Setting
Dorian Pamart, Brieuc Cuvelier, Julie Candiracci, Marielle Herzog
This project is granted by the Walloon Region

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the new poster presentation?

The poster focuses on a novel tool for quantifying H3.1-nucleosomes in fresh whole blood.

Who conducted the research for this project?

The research was conducted by Dorian Pamart, Brieuc Cuvelier, Julie Candiracci, and Marielle Herzog.

What support did the project receive?

The project received funding from the Walloon Region.

How does this tool benefit hospital settings?

This tool aims to improve the measurement of NETs, enhancing patient care.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare NETs hospital diagnostics H3.1-nucleosomes Walloon Region
Last updated: Oct 6, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk